SennaLax-S

Product NDC: 0603-0283
11-digit product format: 006030283
Labeler code: 0603
Product ID: 0603-0283_8ae458b5-3454-4c80-89b3-fbb6773d06e6
Type: HUMAN OTC DRUG
Nonproprietary name: senna and docusate sodium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Par Pharmaceutical
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2007-07-26
Marketing end: 2020-06-30
Substance: DOCUSATE SODIUM; SENNOSIDES
Active strength: 50 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0603-0283		D	Discontinued by firm	2026-10-05
excluded package	package	0603-0283	0603-0283-21	D	Discontinued by firm	2026-10-05
excluded package	package	0603-0283	0603-0283-32	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0603-0283-32	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0603-0283-21	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0603-0283-32	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0603-0283-21	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0603-0283-32	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0603-0283-21	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0603-0283-32	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0603-0283-21	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0603-0283-32	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0603-0283-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0603-0283-32	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0603-0283-21	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0603-0283-32	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0603-0283-21	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0603-0283-32	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0603-0283-21	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0603-0283-32	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0603-0283-21	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0603-0283-32	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0603-0283-21	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0603-0283-32	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0603-0283-21	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0603-0283-32	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0603-0283-21	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0603-0283-21	EA - Each	0603-0283	ba938707-0525-4eb3-a5f5-b1e35b1d1680	1	2014-10-03
0603-0283-32	EA - Each	0603-0283	5dfcc9bd-4c20-469f-86ab-5633f79d7de4	1	2014-10-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
SENNOSIDES	ACTIVE INGREDIENT	3FYP5M0IJX	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
HYPROMELLOSE 2208 (100 MPA.S)	INACTIVE INGREDIENT	B1QE5P712K	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENNALAX-S (SENNA AND DOCUSATE SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
3FYP5M0IJX	SENNOSIDES		SENNOSIDES

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SennaLax-S Tablets	Preferred Pharmaceuticals Inc.	2019-03-21	HUMAN OTC DRUG LABEL	2
SennaLax-S Tablets	Par Pharmaceutical \| Sunrise Pharmaceutical Inc \| Sunrise Pharmaceutical Inc.	2014-09-09	HUMAN OTC DRUG LABEL	3

SennaLax-S

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#